
What We’re Reading: Panel on Sickle Cell Gene Therapy; Infant Mortality Rises; Campaign Against Burnout
A panel of experts agreed that exa-cel, a sickle cell disease gene therapy, was safe enough for clinical use, setting the stage for a potential FDA approval; the United States saw an increase in infant mortality rates for the first time in more than 2 decades; the new antiburnout campaign from the CDC asks leaders to better support health care workers.
Panel Deems Vertex/CRISPR Sickle Cell Gene Therapy Safe for Clinical Use
A panel of experts announced Tuesday that exagamglogene autotemcel (exa-cel), a
US Infant Mortality Rate Rises for First Time in 20-Plus Years
In 2022, the United States saw an increase in infant mortality rates for the first time in more than 2 decades, according to
CDC Campaign Urges Health Care Leaders to Reduce Burnout
The new
Related to this article








